| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1047781705 |
| P356 | DOI | 10.1038/270721A0 |
| P953 | full work available at URL | http://www.nature.com/articles/270721a0 |
| http://www.nature.com/articles/270721a0.pdf | ||
| P698 | PubMed publication ID | 593392 |
| P2093 | author name string | T. Hasegawa | |
| T. Kishi | |||
| M. Yoneda | |||
| Y. Sugino | |||
| Y. Kozai | |||
| E. Higashide | |||
| S. Tanida | |||
| M. Asai | |||
| K. Ootsu | |||
| P2860 | cites work | Journal of Cell Biology | Q1524550 |
| Microtubule Assembly in the Absence of Added Nucleotides | Q35098486 | ||
| Microbiological assays and bioautography of maytansine and its homologues | Q35659506 | ||
| Turbidimetric studies of the in vitro assembly and disassembly of porcine neurotubules | Q48505834 | ||
| Initial studies on the cytotoxic action of maytansine, a novel ansa macrolide | Q66921299 | ||
| Letter: Novel maytansinoids. Naturally occurring and synthetic antileukemic esters of maytansinol | Q67275556 | ||
| Initial studies on maytansine-induced metaphase arrest in 11210 mürine leukemia cells | Q67428026 | ||
| Antimitotic Activity of the Potent Tumor Inhibitor Maytansine | Q67429634 | ||
| Tumor inhibitors. 96. Novel maytansinoids. Structural interrelations and requirements for antileukemic activity | Q69778315 | ||
| Maytansine, a novel antileukemic ansa macrolide from Maytenus ovatus | Q70454786 | ||
| Maytanprine and maytanbutine, new antileukaemic ansa macrolides from Maytenus buchananii | Q104946980 | ||
| Plant antitumour agents: colubrinol acetate and colubrinol, antileukaemic ansa macrolides from Colubrina texensis | Q104960984 | ||
| P433 | issue | 5639 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibiotic | Q12187 |
| Ansamitocin-P-2 | Q77561337 | ||
| Nocardia | Q135175 | ||
| P304 | page(s) | 721-722 | |
| P577 | publication date | 1977-12-01 | |
| 1977-12-22 | |||
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Ansamitocin, a group of novel maytansinoid antibiotics with antitumour properties from Nocardia | |
| P478 | volume | 270 |
| Q71104071 | 3-Amino-5-hydroxybenzoic acid in antibiotic biosynthesis. VI. Directed biosynthesis studies with ansamycin antibiotics |
| Q40416482 | A Bio-Chemosynthetic Approach to Superparamagnetic Iron Oxide-Ansamitocin Conjugates for Use in Magnetic Drug Targeting |
| Q39687671 | A new antitumour ansamitocin from Actinosynnema pretiosum |
| Q34769022 | Abundant and diverse endophytic actinobacteria associated with medicinal plant Maytenus austroyunnanensis in Xishuangbanna tropical rainforest revealed by culture-dependent and culture-independent methods |
| Q33303641 | An integrative expression vector for Actinosynnema pretiosum. |
| Q46099267 | An isolable acyclic hemiacetal of ansamitocin P-3. |
| Q39079147 | Ansamitocin P3 depolymerizes microtubules and induces apoptosis by binding to tubulin at the vinblastine site |
| Q38489049 | Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability |
| Q37235382 | Arylamine N-acetyltransferases in mycobacteria |
| Q43626007 | Asm8, a specific LAL-type activator of 3-amino-5-hydroxybenzoate biosynthesis in ansamitocin production |
| Q33717091 | Biodiversity, bioactive natural products and biotechnological potential of plant-associated endophytic actinobacteria |
| Q46698795 | Biosynthesis and accumulation of ergoline alkaloids in a mutualistic association between Ipomoea asarifolia (Convolvulaceae) and a clavicipitalean fungus |
| Q34242480 | Biosynthesis of 3,5-AHBA-derived natural products. |
| Q89944638 | Bispecific Antibodies and Antibody-Drug Conjugates for Cancer Therapy: Technological Considerations |
| Q44314986 | Cloning and characterization of a gene cluster for geldanamycin production in Streptomyces hygroscopicus NRRL 3602. |
| Q48057934 | Cloning and functional analysis of the naphthomycin biosynthetic gene cluster in Streptomyces sp. CS. |
| Q46324883 | Combination of traditional mutation and metabolic engineering to enhance ansamitocin P-3 production in Actinosynnema pretiosum. |
| Q33231690 | Combinatorial biosynthesis--potential and problems |
| Q88955747 | Complete Genome Sequence of Actinosynnema pretiosum X47, An Industrial Strain that Produces the Antibiotic Ansamitocin AP-3 |
| Q51643648 | Constitutive overexpression of asm18 increases the production and diversity of maytansinoids in Actinosynnema pretiosum. |
| Q45927181 | Constitutive overexpression of asm2 and asm39 increases AP-3 production in the actinomycete Actinosynnema pretiosum. |
| Q36478231 | Cyclization of synthetic seco-proansamitocins to ansamitocin macrolactams by Actinosynnema pretiosum as biocatalyst |
| Q41624821 | Divergolide congeners illuminate alternative reaction channels for ansamycin diversification |
| Q64885629 | Divergolides T⁻W with Apoptosis-Inducing Activity from the Mangrove-Derived Actinomycete Streptomyces sp. KFD18. |
| Q58795500 | Diversity and Applications of Endophytic Actinobacteria of Plants in Special and Other Ecological Niches |
| Q51120941 | Effects of the Methylmalonyl-CoA Metabolic Pathway on Ansamitocin Production in Actinosynnema pretiosum. |
| Q35635029 | Endophytic and epiphytic microbes as "sources" of bioactive agents |
| Q35813522 | Engineered biosynthesis of an ansamycin polyketide precursor in Escherichia coli. |
| Q90419369 | Genome-Scale Metabolic Model of Actinosynnema pretiosum ATCC 31280 and Its Application for Ansamitocin P-3 Production Improvement |
| Q71439904 | Herbimycin B, a new benzoquinonoid ansamycin with anti-TMV and herbicidal activities |
| Q47704987 | Identification and Engineering of Post-PKS Modification Bottlenecks for Ansamitocin P-3 Titer Improvement in Actinosynnema pretiosum subsp. pretiosum ATCC 31280. |
| Q28299278 | Identification of AHBA biosynthetic genes related to geldanamycin biosynthesis in Streptomyces hygroscopicus 17997 |
| Q40620729 | Inhibition of Cilia Regeneration of Tetrahymena by Ansamitocins, New Antitumor Antibiotics |
| Q40734150 | Inhibition of tubulin polymerization by vitilevuamide, a bicyclic marine peptide, at a site distinct from colchicine, the vinca alkaloids, and dolastatin 10. |
| Q34285971 | Macbecins I and II, new antitumor antibiotics. I. Producing organism, fermentation and antimicrobial activities |
| Q39785130 | Maytansine |
| Q42646154 | Mutational analysis and reconstituted expression of the biosynthetic genes involved in the formation of 3-amino-5-hydroxybenzoic acid, the starter unit of rifamycin biosynthesis in amycolatopsis Mediterranei S699. |
| Q36079969 | N-methylation of the amide bond by methyltransferase asm10 in ansamitocin biosynthesis |
| Q44349222 | Occurrence and non-detectability of maytansinoids in individual plants of the genera Maytenus and Putterlickia |
| Q36915975 | Phenotypic change from transformed to normal induced by benzoquinonoid ansamycins accompanies inactivation of p60src in rat kidney cells infected with Rous sarcoma virus |
| Q27003258 | Role of trastuzumab emtansine in the treatment of HER2-positive breast cancer |
| Q39802387 | Secondary metabolism as an expression of microbial growth and development |
| Q46293914 | Selective isolation and ansamycin-targeted screenings of commensal actinomycetes from the "maytansinoids-producing" arboreal Trewia nudiflora |
| Q36949420 | Site-specific growth of Nocardia asteroides in the murine brain |
| Q55429528 | Sources and Fates of Carbamyl Phosphate: A Labile Energy-Rich Molecule with Multiple Facets. |
| Q105035280 | Structures of cyclocarbamides A and B, new plant growth regulators from sp. |
| Q44660273 | The Post-Polyketide Synthase Modification Steps in the Biosynthesis of the Antitumor Agent Ansamitocin by Actinosynnema pretiosum |
| Q38092648 | The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics |
| Q24534370 | The biosynthetic gene cluster of the maytansinoid antitumor agent ansamitocin from Actinosynnema pretiosum |
| Q34089152 | The interplay between mutasynthesis and semisynthesis: generation and evaluation of an ansamitocin library |
| Q59693371 | The structures of macbecin I and II : New antitumor antibiotics |
| Q55257821 | Therapeutic effect of ansamitocin targeted to tumor by a bispecific monoclonal antibody |
| Q36585636 | Trastuzumab-DM1: a clinical update of the novel antibody-drug conjugate for HER2-overexpressing breast cancer |
| Q78234859 | Two New N-(O-Carbamoylglucopyranosyl)-N-dimethylansamitocins from Actinosynnema pretiosum |
| Q38727801 | Two novel cyclic hexapeptides from the genetically engineered Actinosynnema pretiosum |
| Q99548764 | p-Aminophenylalanine Involved in the Biosynthesis of Antitumor Dnacin B1 for Quinone Moiety Formation |
Search more.